2013-09-04 09:36:02 -
Barry Callebaut /
EU Commission approves Barry Callebaut's health claim: Cocoa flavanols support
a healthy blood circulation
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
* Official validation: Cocoa flavanols contribute to normal blood circulation
in human body by helping to maintain elasticity of blood vessels
* New market potential for Barry Callebaut's ACTICOA(® )cocoa powder and dark
* Barry Callebaut's ACTICOA(®) process is the result of year-long research
into preserving cocoa flavanols
Zurich, Switzerland / Wieze, Belgium, September 4, 2013 - Barry Callebaut, the
world's leading manufacturer of high-quality cocoa and chocolate products, today
announced that the
EU Commission approved its health claim submission on cocoa
flavanols (Regulation No 851/2013), following the positive Scientific Opinion
issued by the European Food Safety Authority (EFSA) in July 2012. The company
received the right to use the health claim that "cocoa flavanols help maintain
the elasticity of blood vessels, which contributes to normal blood flow" - the
first in the cocoa and chocolate industry. Barry Callebaut was able to provide
evidence that the daily intake of 200 mg of cocoa flavanols (provided by 2.5 g
ACTICOA(®) cocoa powder or 10 g ACTICOA(®) dark chocolate) supports a healthy
blood circulation by helping to maintain the elasticity of the blood vessels.
Barry Callebaut now has the proprietary right to use the cocoa flavanols claim
within EU countries. The claim can be used for cocoa beverages (with cocoa
powder) or for dark chocolate providing at least a daily intake of 200 mg of
cocoa flavanols. Barry Callebaut will be able to use the claim for its
ACTICOA(®) cocoa and chocolate products which retain most of the cocoa flavanols
naturally present in the cocoa bean.
Barry Callebaut's customers who use ACTICOA(®) cocoa and chocolate products can
apply the claim on their products and packaging. With this, they will be able to
differentiate their offerings from other products on the market. Barry Callebaut
sees new market potential to use the cocoa flavanols claim for - among others -
applications in chocolate drinks, products using dark chocolate and even for the
Peter Boone, Chief Innovation Officer at Barry Callebaut, said: "Receiving the
right to use a health claim on cocoa flavanols by the EU Commission is most
valuable for us as it is a great reward for long years of extensive research.
The health claim is opening up new market potential. Since we received the
positive opinion from EFSA on our submitted health claim, we saw a lot of
interest among our customers."
Herwig Bernaert, Head of Discovery Programs and Global Projects at Barry
Callebaut, added: "The EU Commission's approval marks a milestone in our
research efforts in the healthy ingredients of the cocoa bean. We are very happy
to be able to offer our ACTICOA(®) products with a health claim now, a real
competitive differentiator for our customers."
In July 2012, Barry Callebaut was the first company in the EU to obtain a
positive Scientific Opinion on a health claim on cocoa flavanols by EFSA. Since
2005, the company has carried out more than 20 human clinical studies examining
various impacts of cocoa flavanols on the human body functions. For these
studies, Barry Callebaut used products made through its own developed ACTICOA(®)
process. The company's specific ACTICOA(®) process is the outcome of years of
research into ways of preserving cocoa flavanols. Barry Callebaut succeeded in
maintaining up to 80% of the cocoa flavanols which would otherwise be destroyed
for the most part during the conventional chocolate-making process.
Barry Callebaut (www.barry-callebaut.com):
With annual sales of about CHF 4.8 billion (EUR 4.0 billion / USD 5.2 billion)
in fiscal year 2011/12, Zurich-based Barry Callebaut is the world's leading
manufacturer of high-quality cocoa and chocolate products - from sourcing and
transforming cocoa beans to producing the finest chocolate, including chocolate
fillings, decorations and compounds. Combined with the recently acquired cocoa
ingredients business from Petra Foods, Barry Callebaut generates estimated
annual sales of CHF 6 billion (EUR 4.9 billion / USD 6.4 billion), runs around
50 production facilities worldwide, sells its products in over 100 countries and
employs a diverse and dedicated workforce of more than 8,000 people.
Barry Callebaut serves the entire food industry, from industrial food
manufacturers to artisanal and professional users of chocolate, such as
chocolatiers, pastry chefs, bakers, hotels, restaurants or caterers. The two
global brands catering to the specific needs of these customers are Callebaut(®)
and Cacao Barry(®)
for investors and financial analysts: for the media:
Evelyn Nassar Raphael Wermuth
Head of Investor Relations Head of Media Relations
Barry Callebaut AG Barry Callebaut AG
Phone: +41 43 204 04 23 Phone: +41 43 204 04 58
 See also previous announcement of July 17, 2012: "EFSA issues positive
Scientific Opinion on Barry Callebaut's health claim on cocoa flavanols".
PDF version and image see below links:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Barry Callebaut via Thomson Reuters ONE